Childhood Apraxia of Speech Clinical Trial
— CASOfficial title:
Childhood Apraxia of Speech: Neurobiological and Behavioural Markers and Experience Dependent Changes of Neural Connectivity Induced by Treatment
Verified date | October 2023 |
Source | IRCCS Fondazione Stella Maris |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Childhood Apraxia of Speech (CAS) is a severe speech-language disorder whose aetiological, neuroanatomical correlates are largely unknown. Furthermore, little is known about the neuroplastic effects induced by different treatment approaches and their relationships with the potential changes in the speech behavioural features that express the core deficit of CAS. Twenty four children with idiopathic CAS will be enrolled in a multidisciplinary study aimed at analysing the behavioural and neuroanatomical effects of a specific rehabilitative approach, PROMPT (PROMPTs for Restructuring Oral Muscular Phonetic Targets), that employs tactile-kinesthetic-proprioceptive cues vs a traditional speech-language treatment. The children will be allocated in two arms, one receiving a seven month cycle of individual PROMPT treatment, the other a traditional speech and language treatment for the same amount of time.The pre- and post-treatment speech and language performances and DTI and volumetric MR data will be compared in the two groups.
Status | Completed |
Enrollment | 24 |
Est. completion date | March 30, 2023 |
Est. primary completion date | January 30, 2023 |
Accepts healthy volunteers | |
Gender | All |
Age group | 4 Years to 16 Years |
Eligibility | Inclusion Criteria: - Diagnosis of idiopathic CAS based on the presence of specific diagnostic features of apraxia of speech (see ASHA and Strand et al's criteria) and on a comprehensive clinical and neurological assessment. - Non-verbal IQ within the normal range at standardized tests of intelligence. - Normal structural brain MRI. - Acquisition of parents' informed consent to the execution of behavoiural and neuroradiological assessment at baseline and to perform speech/language treatment. Exclusion Criteria: - Orofacial structural abnormalities. - Known pathologies of neurological, neurometabolical and genetic etiologies. - Audiological deficits. - Epilepsy. - Intellectual disability. - Autism spectrum disorder. |
Country | Name | City | State |
---|---|---|---|
Italy | IRCCS Fondazione Stella Maris | Marina di Pisa-Tirrenia-Calambrone | Toscana |
Lead Sponsor | Collaborator |
---|---|
IRCCS Fondazione Stella Maris | Ministry of Health, Italy |
Italy,
Dale PS, Hayden DA. Treating speech subsystems in childhood apraxia of speech with tactual input: the PROMPT approach. Am J Speech Lang Pathol. 2013 Nov;22(4):644-61. doi: 10.1044/1058-0360(2013/12-0055). Epub 2013 Jun 28. — View Citation
Fiori S, Guzzetta A, Mitra J, Pannek K, Pasquariello R, Cipriani P, Tosetti M, Cioni G, Rose SE, Chilosi A. Neuroanatomical correlates of childhood apraxia of speech: A connectomic approach. Neuroimage Clin. 2016 Nov 4;12:894-901. doi: 10.1016/j.nicl.2016.11.003. eCollection 2016. — View Citation
Kadis DS, Goshulak D, Namasivayam A, Pukonen M, Kroll R, De Nil LF, Pang EW, Lerch JP. Cortical thickness in children receiving intensive therapy for idiopathic apraxia of speech. Brain Topogr. 2014 Mar;27(2):240-7. doi: 10.1007/s10548-013-0308-8. Epub 2013 Aug 24. — View Citation
Morgan AT, Su M, Reilly S, Conti-Ramsden G, Connelly A, Liegeois FJ. A Brain Marker for Developmental Speech Disorders. J Pediatr. 2018 Jul;198:234-239.e1. doi: 10.1016/j.jpeds.2018.02.043. Epub 2018 Apr 25. — View Citation
Namasivayam AK, Huynh A, Granata F, Law V, van Lieshout P. PROMPT intervention for children with severe speech motor delay: a randomized control trial. Pediatr Res. 2021 Feb;89(3):613-621. doi: 10.1038/s41390-020-0924-4. Epub 2020 May 1. — View Citation
Square PA, Namasivayam AK, Bose A, Goshulak D, Hayden D. Multi-sensory treatment for children with developmental motor speech disorders. Int J Lang Commun Disord. 2014 Sep-Oct;49(5):527-42. doi: 10.1111/1460-6984.12083. Epub 2014 Mar 12. No abstract available. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Speech Composite Severity Score changes after 7 months of treatment | Speech Severity Score aggregates measures of DDK, inaccuracy, inconsistency, Phonetic inventory, Syllable Omissions. Score ranges form: 0 (normal) to 5 (severely impaired) | At baselin and at 7 months of individual speech and language training | |
Secondary | Post treatment Diffusion Weighed Imaging (DWI) metrics | Fractional Anisotropy (FA) | At baseline and at 7 months of speech and language training | |
Secondary | Post treatment Diffusion Weighed Imaging (DWI) changes | MD (Mean Diffusivity) | At baseline and at 7 months of speech and language training | |
Secondary | Post treatment cortical volumes modifications | Cortical thickness | At baseline and at 7 months of speech and language training | |
Secondary | Post treatment cortical volumes changes | Volumes analysis | At baseline and at 7 months of speech and language training |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04642053 -
A Randomized Control Trial of Motor-based Intervention for CAS
|
N/A | |
Recruiting |
NCT05185583 -
Methylphenidate in Childhood Apraxia of Speech
|
Phase 2 | |
Recruiting |
NCT05675306 -
Dose Frequency RCT on DTTC in Children With CAS
|
N/A | |
Recruiting |
NCT05916222 -
The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS
|
N/A | |
Completed |
NCT03238677 -
Treating Childhood Apraxia of Speech
|
N/A | |
Recruiting |
NCT03903120 -
ASSIST: Treatment for Childhood Apraxia of Speech
|
Phase 1 | |
Recruiting |
NCT06385470 -
Treatment of Cantonese Speakers With Childhood Apraxia of Speech
|
N/A |